CCL2 and arthritic joint disease: Injection of IL-6 into the affected joints also almost completely reversed arthritis reduction by NFAT5 deficiency (Supplemental Figure 10), suggesting that IL-6, in addition to CCL2, mediates the progression of SAA/NFAT5 axis–dependent arthritis.